DK0450412T3 - Varmebehandlede IgM-antistofpræparater - Google Patents

Varmebehandlede IgM-antistofpræparater

Info

Publication number
DK0450412T3
DK0450412T3 DK91104391.7T DK91104391T DK0450412T3 DK 0450412 T3 DK0450412 T3 DK 0450412T3 DK 91104391 T DK91104391 T DK 91104391T DK 0450412 T3 DK0450412 T3 DK 0450412T3
Authority
DK
Denmark
Prior art keywords
igm
heat
igm antibody
antibody preparations
concentrates
Prior art date
Application number
DK91104391.7T
Other languages
Danish (da)
English (en)
Inventor
Grace C Tsay
Gary Jesmok
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0450412T3 publication Critical patent/DK0450412T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK91104391.7T 1990-04-03 1991-03-21 Varmebehandlede IgM-antistofpræparater DK0450412T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/504,161 US5256771A (en) 1990-04-03 1990-04-03 Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation

Publications (1)

Publication Number Publication Date
DK0450412T3 true DK0450412T3 (da) 1998-02-16

Family

ID=24005109

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91104391.7T DK0450412T3 (da) 1990-04-03 1991-03-21 Varmebehandlede IgM-antistofpræparater

Country Status (9)

Country Link
US (3) US5256771A (de)
EP (1) EP0450412B1 (de)
JP (1) JP3591782B2 (de)
AT (1) ATE155042T1 (de)
CA (1) CA2039387C (de)
DE (1) DE69126727T2 (de)
DK (1) DK0450412T3 (de)
ES (1) ES2104625T3 (de)
GR (1) GR3024910T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297024B1 (en) 1998-10-15 2001-10-02 Cell Activation, Inc. Methods for assessing complement activation
US6235494B1 (en) 1999-02-08 2001-05-22 The Scripps Research Institute Substrates for assessing mannan-binding protein-associated serine protease activity and methods using the substrates
AU2004247021A1 (en) 2003-05-16 2004-12-23 Acorda Therapeutics Compositions and methods including a recombinant human MAB that promotes CNS remyelination
GB0425537D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
FR2959821B1 (fr) * 2010-05-05 2012-07-06 Lab Francais Du Fractionnement Procede de mesure de l'activation du complement par des igg
EP3275897A1 (de) 2016-07-27 2018-01-31 Biotest AG Verfahren zur herstellung von immunoglobulinzusammensetzungen
KR102696143B1 (ko) * 2017-04-07 2024-08-21 아이쥐엠 바이오사이언스 인코포레이티드 보체-의존성 세포용해 효과기 기능의 조정을 위한 변형된 인간 IgM 불변 영역
EP4178978A1 (de) * 2020-07-10 2023-05-17 Grifols Worldwide Operations Limited Verfahren zur herstellung einer zusammensetzung mit menschlichem, aus plasma stammendem immunglobulin m

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2527064C3 (de) * 1975-06-18 1979-11-15 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines intravenösen Nativ-Human-Immunglobulin-Präparates mit natürlicher Halbwertszeit und gegenüber dem Ausgangsmaterial unveränderten Antikörperaktivität
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
JPS56147724A (en) * 1980-04-18 1981-11-16 Teijin Ltd Igm derivative and immunoglobulin preparation for intravenous injection containing said compound as effective component
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
EP0450412A1 (de) 1991-10-09
GR3024910T3 (en) 1998-01-30
US5510465A (en) 1996-04-23
US5612033A (en) 1997-03-18
JPH04221321A (ja) 1992-08-11
JP3591782B2 (ja) 2004-11-24
CA2039387C (en) 2002-02-19
EP0450412B1 (de) 1997-07-09
ATE155042T1 (de) 1997-07-15
DE69126727T2 (de) 1997-10-23
ES2104625T3 (es) 1997-10-16
CA2039387A1 (en) 1991-10-04
US5256771A (en) 1993-10-26
DE69126727D1 (de) 1997-08-14

Similar Documents

Publication Publication Date Title
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
DE69333107D1 (de) Dualer träger für immunogene konstrukte
ATE320448T1 (de) Gereinigte primate clta-8 antigene und verwandte reagenzien
ATE128732T1 (de) Antigenkonstrukte von ''major histocompatibility complex'' klasse i antigenen mit spezifischen trägermolekülen, ihre herstellung und verwendung.
DK0450412T3 (da) Varmebehandlede IgM-antistofpræparater
EP0091760A1 (de) Anti-Immunkomplex-Antikörper und Verfahren zur Herstellung desselben
KR880701108A (ko) 면역조절 조성물 및 이들의 용도
AU8185494A (en) Diagnostic assay for alzheimer's disease
FI903827A0 (fi) Foerfarande foer reducering av immunoglobulin e-responser.
ZA9210006B (en) Anti-human IgE monoclonal antibodies.
Grant et al. Reversed in vitro anaphylaxis induced by anti-IgG: specificity of the reaction and comparison with antigen-induced histamine release
DE10299038I2 (de) Pl{ttchen-spezifisches Chim{risches immunglobulin.
Wolff et al. A two-component system of human serum agglutinating gelatine-coated erythrocytes
Edwards et al. Pseudoimmune precipitation by the isolated byssinosis “antigen”
Pernis et al. Identical allotypic markers of heavy polypeptide chains present in different immunoglobulin classes
Knight et al. Distribution of covalently bound and non-covalently bound secretory component on subclasses of rabbit secretory IgA
Gold et al. Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide
ATE111606T1 (de) Ein gattungsspezifisches listeria-antigen, identifiziert durch monoklonale antikörper.
Muschel et al. Re-examination of the Neisser—Wechsberg (antibody prozone) phenomenon
Lang et al. Production of goat, rat, and guinea pig antisera to murine IgE
IL86578A0 (en) Immunoassay
Stux et al. Heterogeneity of rabbit homologous skin sensitizing antibodies: IgE and a new subclass IgGa
Beernink et al. Proteins adhering to Escherichia coli after exposure to guinea-pig serum
AU3283693A (en) Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy
Outschoorn Subclass specificities of rabbit antibodies to human antidextran.